Skip to main content
Clinical Trials/NCT02031913
NCT02031913CompletedNot Applicable

Association Between Insulin Resistance and Hepatic Fibrosis in Combined Chronic Hepatitis B and Non-alcoholic Fatty Liver Disease

Seoul National University Boramae Hospital1 site in 1 country500 target enrollmentStarted: January 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
500
Locations
1
Primary Endpoint
Insulin resistance and fibrosis indices

Study Overview

Brief Summary

Hepatic steatosis and insulin resistance are associated with severity of fibrosis in non-alcoholic fatty liver disease (NAFLD) and chronic hepatitis C. However, clinical significance of steatosis and insulin resistance on fibrosis in chronic hepatitis B (CHB) is not well established. The aim was to investigate the relationship between insulin resistance, hepatic steatosis, and fibrosis in patients with CHB.

Detailed Description

acoustic radiation force impulse elastography

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
20 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Chronic hepatitis B patients
  • With evidences of hepatic steatosis on ultrasonography or pathology

Exclusion Criteria

  • significant alcohol consumption or other known liver diseases

Outcomes

Primary Outcomes

Insulin resistance and fibrosis indices

Time Frame: one year

Measurement for insulin resistance and fibrosis index for hepatic fibrosis assessment

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Seoul National University Boramae Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Won Kim

M.D, PhD

Seoul National University Boramae Hospital

Study Sites (1)

Loading locations...

Similar Trials